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Abstract
Objectives: An assessment of the current status of magnetic resonance imaging (MRI) was undertaken
to provide input for future government decisions on the introduction of new technologies in Asia. The
objective of the study is to describe and explain the diffusion pattern of this costly technology in several
Asian settings.
Methods: Data on the diffusion pattern of MRI for different Asian countries (the Republic of Korea,
Malaysia, Indonesia, the Philippines and Thailand) and regions (the cities of Shanghai and Hong Kong
in China and the state of Tamil Nadu in India) were obtained from national representatives of profes-
sional bodies by using standardized questionnaires for the year 1997–98. In addition, utilization data
were collected at the hospital level in three countries before and after the economic crisis in the re-
gion. For four countries plus Hong Kong, background information on the legal framework for “big ticket”
technologies was collected.
Results: Since the introduction of the first MRI in the region in 1987, the number of MRIs has gradually
increased both in public and private facilities in Asia. In 1998 the average number of MRI machines
installed varied from less than 0.5 machine per million population to more than 5 machines per million
population. The maintenance and operating costs, and not the absence of regulation, account for the
low number of MRIs in the Philippines and Malaysia. Overall, installed MRIs have low magnetic field
strength, vary with respect to brand and type, and are mostly in the private sector and in the urban
areas of the region. The diffusion pattern of MRIs in countries of the Asian region appears to follow two
types of patterns of diffusion: one set of countries seems to be composed of mostly early adopters and
another set of countries appears to be composed mostly of late adopters.
Conclusions: Total number of MRIs per population in this region, though quite small compared to most
OECD countries, reflects a higher share of the country’s healthresource devoted to expensive high-
technology devices. It is difficult to state the appropriate number of MRIs for each country; however, the
study shows that there are observable problems in terms of efficiency, equity, and quality of MRI services.
The research team proposes a few key recommendations to counteract these problems. Purchasing
and regulatory bodies must be empowered with skill and knowledge of health technology assessment.
Likewise, the fundamental problems resulting from inefficient and unfair health financing should not be
overlooked, so that there is more equitable use of the technology.
Keywords: Magnetic resonance imaging, Health technology assessment, Diffusion, Economic impact,
Developing countries
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Switzerland and the Health Systems Research Institute (HSRI) in Bangkok, Thailand for providing financial
support for the group’s meetings. The views expressed are those of the Asian MRI Study Group, and are not
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Since its introduction in the early 1980s, magnetic resonance imaging (MRI) has be-
come a familiar part of medical apparatus available for the diagnosis of different con-
ditions. Its rapid diffusion has been documented in several countries, mostly developed.
By 1993, there were more than 4,000 units worldwide (16). In the United States alone,
over 2,700 were in use by 1997 (13). Similar information is less available for developing
countries.
There are several routes for the diffusion of technology in developing countries (3). In
the public sector, a common route is through “tied aid,” where purchase of equipment is
conditional on sourcing from the donor country. In the private sector, one major route is
through investments by individuals or groups of individuals who believe there is a market
for such equipment and have the capital to invest. In many cases, these individuals are
wealthy doctors who bring in equipment, which they themselves use.
In both public and private sectors, a marketing strategy commonly employed is a rent-
free “loan” of new equipment. The cost of the equipment is bundled into prices of reagents
set in an exclusivity contract between the health facility and the supplier. If the full cost
of the equipment cannot be bundled into the cost of supplies and consumables, an option-
to-buy clause after a prespecified rent-free loan period is specified in the contract. This
loan period is usually long enough to create dependence of the health facility on the loaned
equipment. Thus, an optional action becomes, more often than not, mandatory to avoid
disruption of set routines. A final route of technology acquisition in developing countries
is through universities and research institutes, which collaborate with their counterparts in
the developed world and get equipment as part of their share in the research grants.
In many of the developing countries, technology can enter “generally without control
or supervision by any agency of the receiving government” (3). Lack of regulation gives
rise to several areas of concern about the quality of care provided, as discussed below.
Once the market for equipment has been established, a stream of upgrades can follow.
Hospitals are judged on their technological superiority by clients who believe that the
more sophisticated the equipment, the better the care (17). Thus, a “me too” phenomenon
is spawned. Hospitals, despite their close proximity with each other and potential ease
of referral, will insist on in-house availability of equipment. Smaller or lower capitalized
hospitals will attempt to purchase equipment, albeit of a lower model and cost. Discards
from hospitals in developed countries that have upgraded are purchased by hospitals in
developing countries on a second-hand basis. Depending on how old these models are,
some models may run into maintenance problems because the manufacturer may have
discontinued production of spare parts.
When imported technology is tied to sourcing from the donor country, problems may
arise with maintenance and availability of spare parts (4), especially if there is no local
distributor. Once funding assistance has been accepted, “white elephants” loom on the
horizon. Another area of concern is the scarcity of qualified individuals to maintain the
machine in good working condition, to operate the machine, and to interpret the results.
The few qualified individuals present in health facilities are constantly being “pirated” by
rival hospitals within or even outside the country.
The phenomenon of the physician-entrepreneur has been described elsewhere (17).
Physicians become entrepreneurs when they purchase expensive equipment from which
they expect a profitable return on investment. This places the physician in a potential
conflict-of-interest position (1). On the one hand, the physician is expected to act on be-
half of his patients and undertake diagnostic and treatment interventions based on med-
ical indications. On the other hand, he is an entrepreneur who wishes to recoup his in-
vestment in a reasonably short period of time and may be tempted to take advantage
of situations where indications are not explicitly stated, or are vague with considerable
leeway.
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Such concerns make it imperative to understand the extent and determinants of the
system-wide diffusion and utilization of new medical technologies, which are believed to
drive healthcare costs upward (14).
THE ASIAN MRI STUDY GROUP AND OBJECTIVES
In 1997 and 1998, some Asian countries witnessed a dramatic recession of their economies
and the viability of some of their expensive investments in health were threatened. The onset
of the economic crisis in Thailand was in July 1997, immediately followed by Indonesia
and some months later by the Philippines. In the same period, members of the Asian
Health Technology Assessment Network met twice in Bangkok, Thailand (December 1997
and March 1998) to discuss the details of their first collaborative project on the diffusion
and utilization of healthcare technology and its impact on quality of care. The following
countries were represented in this collaborative study: China (represented by Shanghai and
Hong Kong), India (represented by the State of Tamil Nadu), Indonesia, Republic of Korea,
Malaysia, the Philippines, and Thailand (Appendix 1).
MRI was selected as the technology to be evaluated because of its potential to illustrate
some of the concerns previously mentioned. MRI is an important imaging modality for
examinations of the brain, spine, head, and neck. It is a relatively new imaging method that
uses a combination of magnetic fields and radio waves. Being a piece of imaging equipment,
it was felt that there would most likely be central sources of data on the presence of MRIs
in different hospitals because of licensing requirements and safety concerns.
Costs and technical performance of MRIs are likely to vary, depending on the type
and strength of their magnets. Hence, it was thought that the presence of different technical
specifications of magnets of MRIs might lead to different patterns of diffusion (i.e., because
of lower costs of purchase and maintenance for type of magnet) and utilization (i.e., expec-
tation of higher resolution and better images with magnets of higher strengths) that could
be analyzed in the study.
The following objectives of the Asian MRI study group were agreed upon:
 To compare the diffusion of MRI in each country according to type of technology acquired, mode
and time of acquisition, and host institution by location, ownership, type and size of institution, and
teaching status;
 To determine variables in the economic, legal/regulatory, and healthcare sector environment that
can potentially explain differences in the diffusion of MRI in each country;
 To describe utilization patterns of MRI in selected hospitals in each country; and
 From the different country experiences, to provide general recommendations to facilitate rational
diffusion and utilization of MRI.
In October 1998 a final meeting was organized in Khonkaen, Thailand, where the individual
countries presented their results. This article reports the final results of this collaborative
initiative.
METHODS
Data Collection
All countries participated in the diffusion phase of the study, and depending on the avail-
ability of institutional resources, also in the utilization phase of the study. Most recent
data, preferably 1997–98, were collected at the national level for the diffusion study and at
the hospital level for the utilization study. For pragmatic reasons, in the two largest study
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countries, India and China, data collection was limited to the regional level. For India, data
came from the State of Tamil Nadu, while China limited its data collection to Shanghai
and Hong Kong. A standardized questionnaire was developed for the survey and distributed
among the participating members of the project. Data were entered centrally using MS
Excel™, and descriptive statistics were generated.
Data Sources
National Level Data Including MRI Diffusion Data. To give a general picture
of the member countries in the study, main demographic, epidemiologic, socio-economic,
and financial features at country level were collected from the different sites (e.g., total
population, life expectancy at birth, proportion of urban versus rural population, literacy
rate, poverty threshold, etc.). Most of the data from the national level came from existing
documents from different national ministries and regulatory bodies, supplemented with key
informant interviews and small, purposeful surveys. Missing country or province data were
completed using the World Development Indicators/World Bank database (19).
Key variables collected on the adoption and diffusion of MRI in the different study
sites were the total number of MRIs installed, year of first MRI installed, brand names, MRI
strength, type of MRI, location, and ownership. Key informant interviews were carried out
to determine the influence of regulatory and nonregulatory factors on the decision of a health
facility to acquire an MRI.
Hospital Utilization Level Data
For the hospital level of data collection, convenience sampling was based on access to
patient records in a hospital (preferably public and Ministry of Health). One hundred con-
secutive patient charts were sampled in two time periods: approximately 3 months before and
3 months after the onset of economic recession. The remaining data were gathered by key
informant interviews of the administrators of the hospital and by focus group discussion with
physicians using MRI facilities. Key variables collected were number of patients, includ-
ing background information of the patients who underwent MRI scan, sites of organ scan,
specialty of the prescriber of the MRI, and mode of payment of each patient receiving MRI.
RESULTS
General Description of the Study Countries
General country information is found in Table 1. Except for Hong Kong, we report the
national numbers and features of all the member countries in the project. The study countries
represented almost 44% of the global population in 1998 (19). Most of the study countries
have a predominantly rural population. The top three study sites with the highest ratio
of health spending to gross domestic product (GDP) are Hong Kong, Republic of Korea,
and Thailand (more than 5%). Furthermore, the public health component of total health
expenditure varies from around 22% in India to 56% in Malaysia (19).
Diffusion Pattern
As an indicator of medical technology in the region, the number of computed tomography
(CT) scans per million population shows wide variation (e.g., 179 CT scans per million
population for the Republic of Korea compared with 0.3 CT scan per million population in
Indonesia) (Table 2).
MRI Availability. The number of MRI per million population shows quite similar
patterns to those of the number of CT scans in the study countries (Table 2). The same
countries anchor the high (Korea) and low (Indonesia) ends of distribution for both MRIs
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Table 2. Number, Number per Million, and Year of First Installed MRI in the Asian Region
Number of Total number Number of Year of Average number of
CT scans of MRI MRIs per first MRI MRIs adopted
Country per million by 1998 million installment per year
Shanghai (China) 67 12 0.92 1987 1.0
Tamil Nadu (India) NA 10 0.18 N.A. N.A.
Indonesia 0.3 9 0.13 1990 1.1
Republic of Korea 179 245 5.4 1988 24.5
Malaysia 3.3 26 0.8 1990 3.3
Philippines 1.1 11 0.16 1989 1.2
Thailand 3.8 28 0.47 1988 2.8
Hong Kong (China) 2.1 12 1.81 1992 2.0
and CT scans. Roughly the region can be categorized into three groups according to MRI
availability: a) the Republic of Korea with more than five machines per million population;
b) Hong Kong, Shanghai, and Malaysia with approximately 1–2 machines per million
population; and c) Thailand, Tamil Nadu, Indonesia, and the Philippines with less than 0.5
machine per million population.
Adoption Rate. In general the study sites adopted their first MRI during the period
from 1987–90. In terms of average adoption rate, the Republic of Korea has the highest rate
with 24.5 MRIs per year, followed by Malaysia (3.2 MRIs per year), Thailand (2.8 MRIs
per year) and Hong Kong (2.0 MRIs per year). The remaining study countries introduced
less than 2 MRIs on average per year.
Figure 1 gives a more detailed pattern of the adoption of MRI in the region. The hori-
zontal axis plots the year of adoption—starting from 1987 when the first MRI was installed
in the region—while the vertical axis denotes the total MRIs installed per million population
at the different study sites. The steeper curve for the Republic of Korea starting in 1988
characterizes it as an early adopter, with a persistent increase until 1998. The remaining
study sites have an almost straight or concave curve, characterized as predominantly con-
sisting of early adopters of MRI but resulting only in a small increase of MRIs per million
population.
Figure 1. MRI diffusion pattern for study countries from 1986 until 1998 (per million
population).
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Table 3. MRI Ownership Characteristics in the Asian Region
Country (number Public/private Hospital/free- Capital/rural University/ Tertiary
of MRIs in 1998) ownership ratio standing ratio ratio others care/others
Shanghai, China (12) 100/0 100 NA 13/67 83/17
Tamil Nadu, India (10) 0/100 90 40/60 20/80 100/0
Indonesia (9) 33/67 89 66/33 22/78 NA
Republic of Korea (245) 0/100 95 40/60 30/70 29/71
Malaysia (26) 31/69 100 100/0 8/92 100/0
Philippines (11) 0/100 91 60/40 27/73 100/0
Thailand (28) 68/32 68 68/32 29/71 NA
Hong Kong, China (12) 50/50 100 NA 17/83 NA
Ownership and Location. All of Shanghai’s MRIs are owned by the government,
whereas Thailand has 68% and Hong Kong has 50% in the public sector. In the remaining
countries, all (Philippines and Korea) or a majority (Indonesia and Malaysia) of MRIs are
owned privately. Many of them are located in non–university-affiliated tertiary care hospi-
tals. Thailand has the unique phenomenon of hosting a third of their MRIs in freestanding
locations (Table 3).
Technical Characteristics. On average, about half of the MRI units installed (ap-
proximately 50%) in the selected countries have a low magnetic field strength (MFS). On
both extremes are Tamil Nadu and Hong Kong: 90% of the MRIs installed in Tamil Nadu
have a low MFS, while Hong Kong has MRIs with either middle or high MFS. The majority
of the MRIs in Indonesia, Malaysia, Thailand, Republic of Korea, and the Philippines are
superconducting electromagnet MRIs (Table 4).
Brand. No single brand is dominating the market or has a monopoly in the region.
On average, almost 50% of the market share is possessed by Siemens and General Electric
(Table 4).
Purchase Costs. For Thailand, acquisition costs range from US $1 million to
$2.1 million with poor to good perceived viability. For the Republic of Korea, purchas-
ing costs by lease vary from $200,000 to $270,000. Purchase cost in the Philippines is $1
million to $2 million, of which maintenance costs are approximately $25,000.
Regulatory Framework
Description of the regulatory framework is based on the experience of Thailand, Malaysia,
Republic of Korea, Hong Kong, and the Philippines (Table 5). Based on expert opinion,
some form of legal framework for the acquisition of big-ticket technologies is absent or is
only applicable to the public sector in these countries. For example, no formal procedure like
a certificate of need mechanism is required by a governmental body. Instead, a justification
of need has to be delivered by the Ministry of Public Health in the case of Thailand or by
the Hospital Authority Board in Hong Kong. For the Philippines, it is not even necessary
to produce documentary evidence of the effectiveness and safety of the technology before
purchasing. A description of the technical specifications suffices as a basis for making a
purchase decision, particularly in hospitals in the private sector.
In all five study sites, there is a regulatory body (e.g., Ministry of Health, Hospital
Chief or Hospital Authority Board) that approves the purchase of the technology. Brands
are chosen through open or public bidding. In all the study sites, decisions on which brand
to buy are made by physicians (Republic of Korea) or tender or a bidding board (Malaysia,
the Philippines, Thailand, and Hong Kong). According to experts in all the countries, there
is no financial incentive (e.g., tax-free importation) to purchase an MRI.
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Based on the survey, the considerable maintenance and operating costs tend to be
a restraining factor for the adoption of MRI. In some of the countries, specifications or
upgradability, rather than price or length and type of service of the technology, are important
decision features during the purchase process.
Finally, comparing the distribution of MRIs with regard to ownership (Table 3), there
is a tendency of countries with a rather weak regulatory framework to have predominantly
private MRIs .
Utilisation Pattern
Only three study countries succeeded in collecting pre- and postcrisis utilization data
(Thailand, Korea, and the Philippines) for about 100 patients. Only data on MRI from
private hospitals are included. An overview of the utilization pattern is given in Table 6.
Patient Characteristics. In the three study countries, there is almost the same pro-
portion of male to female patients receiving MRI. The mean age of the patients ranges
from late 30s to late 40s. Outpatients make up the majority of patients receiving MRI in
Thailand and the Philippines, but this is not true in Korea, where two-thirds of the patients
who receive MRI are hospitalized.
Table 6. Utilization Pattern of Republic of Korea, Philippines, and Thailand
Republic of Korea Philippines Thailand
Before After Before After Before After
Utilization data crisis crisis crisis crisis crisis crisis
Number of patients 96 94 100 100 100 100
Average waiting time (days) 3.5 3.5 NA NA 0 0
Sex
Female 45% 43% 45% 37% 52% 54.0%
Male 54% 56% 55% 63% 48% 46%
Mean age 42 45 37.6 37.7 49 47
Proportion of outpatients 29% 36% 100% 94% 61% 71%
Organ
Brain 59% 48% 44% 38% 36% 34%
Head & neck 0 0 0% 0% 16% 10%
Spine 16% 19% 36% 39% 40% 45%
Muscular skeletal 8% 9% 7% 17% 1% 6%
Abdomen/pelvis 5% 6% 8% 4% 1% 0%
Cardiovascular 0 0 0% 0% 0% 1%
Others 0 0 0% 0% 5% 4%
Specialty
Neurologist 42% 44% NA NA 33% 20%
Orthopedic surgeon 13.5% 20% NA NA 38% 40%
General Practitioner 4.5% 1% NA NA 3% 1%
Others 40% 35% NA NA 26% 39%
Payment method
Out of pocket 100% 100% NA 67% 71% 65%
Private insurance (in full) 0 0 NA 10% 0% 12%
Private insurance with copay 0 0 NA 1% 29% 13%
Public insurance (in full) 0 0 NA 0 0% 4%
Public insurance with copay 0 0 NA 0 0% 5%
Others 0 0 NA 0 0% 0%
Charity 0 0 NA 0 0% 0%
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Area Imaged/Indication for Imaging. Utilization data from the three study sites
show that in general, MRI is performed in accordance with proven clinical applications.
Overall, brain and spine examinations account for approximately 70% of the workload in
all study sites. For the Republic of Korea, over half of MRIs are for brain examination,
while in Thailand the majority of the MRI examinations were used for the spine (Table 6).
Specialty of Referring Physicians. Only two countries had data on the refer-
ring physician. In Thailand most patients were referred by orthopedists for musculoskele-
tal/orthopedic diagnosis, while in the Republic of Korea the predominant group utilizing
MRI were mostly radiologists for neurological diagnosis.
Fees and Mode of Payment by Patients. In the three countries, many patients
pay out-of-pocket for MRI services. In Thailand and the Philippines there is a proportion
of patients who get the services with some form of public or private insurance, with full
or partial coverage. The impact of the economic crisis can be seen in the case of MRI
services in Thailand. The proportion of patients paying out of pocket for MRI investigation
decreased from 71% to 65%. The average charge of an MRI examination of the head in
Thailand and the Republic of Korea is approximately US $191 and $357, respectively.1 For
comparison, the average charge for a CT scan of the head in Thailand and the Republic of
Korea is only $122 and $120, respectively.
DISCUSSION
The Asian countries involved in the study display a wide spectrum of economic productivity
as measured in terms of GDP per capita. This spectrum of GDP per capita is also reflected
in the spectrum of the number of MRIs per million population, which varies tenfold from
a high of 5 per million population in Korea to a low of less than 0.5 MRI in Indonesia and
the Philippines. Not surprisingly, there is some concordance between GDP per capita and
MRI per million population.
If we compare the current average number of MRIs per million population in Asia with
other regions of the world, it can be concluded that it is quite modest. Using the average
of 1.3 MRIs per million population in the countries involved in this study, the region as a
whole would be ranked at the bottom of the Organization for Economic Cooperation and
Development (OECD) list of MRIs (Figure 2). However, as previously stated, the average
hides a considerable spread, and some Asian countries like Korea, an OECD member, can
compare favorably with other OECD countries. Furthermore, taking into consideration the
total health expenditure per capita, Figure 2 supports the findings by Lazaro and colleagues
(10) that lower income economies devote a larger fraction of their health expenditure to
expensive big ticket medical technologies compared with the same fraction in high-income
countries. Because there is no “gold standard” for the appropriate number of MRIs per
inhabitants, it is difficult to claim whether this number is too low or what the ideal number
of MRIs in the region should be.
From the results, there appear to be two patterns of diffusion of big-ticket items such
as MRIs. One set of countries seems to be composed of mostly early adopters, and another
set of countries appears to be composed mostly of late adopters. There appears to be no
concordance of the pattern of diffusion with either the presence of a regulatory framework
or the absolute numbers of MRIs. It was initially hypothesized that a pattern of late adoption
would be seen if there was a regulatory framework that required evidence of effectiveness
before an MRI can be approved for purchase. For example, in Canada the MRI was first
introduced as a research tool in 1982, and the first clinical use was in 1985. There was slow
diffusion of MRI technology because of Canada’s global budgeting system of the Canadian
hospitals. There were little funds to buy new, expensive technology like the MRI, and a
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Figure 2. Number of MRIs per population and total health expenditure (US $) in study
countries (black columns) and selected OECD countries (patterned column) in 1998. Total
health expenditure per capita figures for Shanghai and Tamil Nadu are from the national
average.
technology assessment report emphasized the lack of evidence of the diagnostic superiority
of MRI (4).
On the other hand, in Japan, which most recently became first in terms of MRIs installed
per million population, the main determinants of diffusion include the technical attributes,
the market situation of the medical engineering industry, the reimbursement system, and
Japan’s sociocultural background. It was specifically mentioned that the introduction of
MRI in Japan was not linked to formal assessments of effectiveness (9). Perhaps the Asian
experience of rapid adoption and diffusion of MRI in primarily private and urban areas is
facilitated not only by the lack of a regulatory framework that is implemented in the public
as well as the private sector, but also by the sociocultural context. In particular, the so-called
“me too” phenomenon coupled with the economic surplus in those early years could explain
the rapid and widespread use of this technology. As mentioned earlier, competitiveness of
hospitals is judged by their technological superiority by clients who believe that the more
sophisticated the equipment, the better the care.
The relatively low number of MRIs per million population that have been installed in
the Asian region—in comparison with the OECD numbers—is a quite remarkable finding
of this study (except in the case of Korea). Before the onset of the financial crisis in 1997,
when the Asian economies were booming, one would expect more MRIs to have been
installed. Also, because of the absence of a regulatory framework in this region for big-
ticket technologies like MRIs, there would be no barriers, other than economic, to investing
in such technologies. Evidence from the early 1980s in the United States showed that
certificate of need stringency had a strong negative impact on the adoption of the first MRIs
in that country (18). Thus, it appears that the limited number of MRIs in the region is
probably due to its high acquisition cost, and perhaps also to lack of technical know-how
on the part of the investors and the availability of better investment potentials other than
high-tech technologies.
Probably because of lower or even no acquisition costs either through second-hand
purchases or through donations, many MRIs with low MFS are present in the region.
However, this does not necessarily imply low-quality imaging. Literature shows that the
relationship among the variables contributing to image quality is complex and extends far
beyond MFS (2;11;12;15). In addition, there are no completed studies that can directly
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demonstrate the superiority of higher MFS over low MFS. Preliminary results from two
studies show no significant diagnostic difference between low (0.5 or 0.64 Tesla [T]) and
high (1.5 T) MFS (11;12).
The utilization pattern of the study findings are in accordance with the existing evidence
where diagnostic improvements resulting from MRI mainly involve the central nervous
system, the spinal cord, and the neuromuscular system (16). However, because of the
continuing heavy financial burden of maintenance and operation of an MRI, there is danger
of shifting to examinations of organs where MRI still has some limited application. It was
hypothesized that a change in utilization patterns might be demonstrated before and after
the crisis, but this was not shown in the limited data available.
Looking at international experience on appropriate use of MRIs, there are similarities
with the Asian experience. For example, in British Columbia, 69.4% of MRI services were
for patients referred by neurologists. Only 4.5% were referred by general practitioners
(13). Among in-patients in France, neurologic and neurosurgical indications accounted for
two-thirds of MRI examinations (5). During the first years of its introduction in the United
States, procedures involving the head and spine accounted for 77% (6).
The countries in this collaborative initiative were part of the surging world economy
in the early 1990s and, due to the increased wealth in the region and increased education of
its populace, demand for health care grew and the private sector expanded to account for
40% to 81% of healthcare expenditures. Most of the expensive technology, like the MRI,
now belongs to the urban and private sector (4). Access has been limited by geography
and ability to pay, bringing issues of equity into focus. A detailed study in eight hospitals
in Thailand shows that there is inequity in terms of MRI access among different payment
groups. The rate of MRI utilization is much lower for those under the public assistance
scheme compared with those paying out-of-pocket or those covered by the Civil Servant
Medical Benefit Scheme (7).
To avoid cost escalations and inefficiencies in national health systems, it is recom-
mended that legal frameworks and regulatory bodies be strengthened for the introduction
of big-ticket technologies in both public and private sector. In particular, implementation
of regulations in the private sector should be taken as a policy opportunity to improve the
delivery of health care. For example, a certificate of need plus a technology assessment
report could be required from those who plan to acquire such machines. For several of the
countries in the study, there is no agency formally tasked to undertake health technology
assessment. Expertise in this area needs to be built up, because some technology assessment
reports from the developed countries cannot be imported in total for direct application to
developing countries. Authorities need to be able to decide which parts of the technol-
ogy assessment report can be generalized to their own setting and which ones will need
adjustment or tailoring.
In addition, unequal access to such services, such as for rural populations and disadvan-
taged groups, could be improved through more equitable financing. The wide spectrum in
the number of MRIs per million population only demonstrates variations among countries
and at the most can be interpreted as a signal that there may be evidence of under-availability
in some countries and even excess availability in others.
The conclusions of this collaborative study need to be interpreted with caution. First,
due to the pragmatic approach of the collaborative initiative, it has to be emphasized that
the study has a descriptive retrospective design that limited the ability to analyze the data in
an ideal way. Second, some data, in particular on utilization, were incomplete and outdated
by the time this study was published. Third, for pragmatic reasons we had to limit country
experiences of India and China to regional data. Fourth, the study sites have different health
systems and epidemiologic profiles that make the direct comparison of MRI diffusion and
utilization problematic. This limits our ability to completely understand and analyze the
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diffusion of MRIs in the region. We are well aware of the complex combination of economic,
organizational, political, institutional, medical, social-demographic, and cognitive factors,
and this varies in time. We believe, however, that the patterns shown in this study highlight
a common area of concern: the need for incorporating health technology assessment tools
in policy making in Asia.
Despite the limitations of the study, one can clearly say that the present healthcare
systems in the countries studied, as exemplified in this one-time, limited case study on MRI
diffusion and utilization, still deviate from the ideal as described by Hillman et al. (8) as
early as 1985:
In an optimal medical care system, new technologies and innovations would be adopted rapidly once
their safety and efficacy are established and once favourable cost-effectiveness ratios are anticipated.
The technologies would be purchased and sited in the most efficient and appropriate settings and
would be available equally to everyone in need. Payment would reflect the actual costs of appropriate
and efficient medical care at all time, regardless of which technologies are used and whether they are
cost-saving or cost-increasing (9).
NOTE
1The costs associated with receiving an MRI examination vary widely depending on the com-
plexity of the images required, physicians’ charges for interpretation, and other variables.
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APPENDIX 1
List of Investigators in Alphabetical Order with Their Affiliation During the
Study
SHANGHAI CITY, CHINA
Professor Jie Chen, Professor Hengjin Don, and Dr. Lu Jun, Shanghai Medical University, Shanghai
HONG KONG CITY, CHINA
Dr. Lim Siew Peng and Dr. Dickson Chang, Hospital Authority, Hong Kong
STATE OF TAMIL NADU, INDIA
Dr. K. R. John, Christian Medical College, Vellore
INDONESIA
Dr. Puruhito, Airlangga University, Dr. Soetomo Hospital, Surabaya;
Dr. Sukanto Sumodinoto and Dr. Wahyu Dwi Asutuiti, Center for Health System Research and
Development, Surabaya
REPUBLIC OF KOREA
Dr. Chang-Yup Kim, College of Medicine, Hallym University, Kangwon-do;
Dr. Sun M. Kim, Seoul National University, Seoul; and
Dr. Young-sung Lee, Chungbuk National University, Chungbuk
MALAYSIA
Dr. P. Sathyamoorthy, Hospital Kuala Lumpur, Kuala Lumpur
THE PHILIPPINES
Dr. Jose´ Acuin and Dr. Teresa Pascual, De La Salle University, Dasmasrinas, Cavite;
Dr. Anette Peralta, Radiation Health Service, Department of Health, Manila; and
Dr. Tessa Tan-Torres, University of the Philippines, Manila
THAILAND
Dr. Piya Hanvoravongchai, Health Systems Research Institute, Ministry of Public Health, Thailand;
Mr. Raymond Hutubessy and Mr. Mana Vatakul, WHO Collaborating Center on Health Economics,
Chulalongkorn University, Bangkok
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